Works matching IS 0344-5704 AND VI 78 AND IP 2 AND DT 2016

Results: 26

Identifying novel therapeutic agents using xenograft models of pediatric cancer.

Published in:

2016

By:

Kurmasheva, Raushan;
Houghton, Peter;
Kurmasheva, Raushan T;
Houghton, Peter J

Publication type:

journal article

High TUG1 expression is associated with chemotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.

Published in:

2016

By:

Jiang, Lin;
Wang, Wenchao;
Li, Guoli;
Sun, Canlin;
Ren, Zhenqin;
Sheng, Haihui;
Gao, Hengjun;
Wang, Chaofu;
Yu, Hong

Publication type:

journal article

A Phase I study of safety and pharmacokinetics of fruquintinib, a novel selective inhibitor of vascular endothelial growth factor receptor-1, -2, and -3 tyrosine kinases in Chinese patients with advanced solid tumors.

Published in:

2016

By:

Cao, Junning;
Zhang, Jian;
Peng, Wei;
Chen, Zhiyu;
Fan, Songhua;
Su, Weiguo;
Li, Ke;
Li, Jin

Publication type:

journal article

Rho GTPases: RAC1 polymorphisms affected platinum-based chemotherapy toxicity in lung cancer patients.

Published in:

2016

By:

Zou, Ting;
Yin, Jiye;
Zheng, Wei;
Xiao, Ling;
Tan, Liming;
Chen, Juan;
Wang, Ying;
Li, Xiangping;
Qian, Chenyue;
Cui, Jiajia;
Zhang, Wei;
Zhou, Honghao;
Liu, Zhaoqian

Publication type:

journal article

Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors.

Published in:

2016

By:

Smith, David;
Powderly, John;
Lee, James;
Shepard, Dale;
Wallin, Johan;
Chaudhary, Archana;
Chao, Grace;
Ng, Wee;
Mitchell, Malcolm;
Grau, Gerrit;
Kurek, Raffael;
LoRusso, Patricia;
Smith, David C;
Lee, James J;
Shepard, Dale R;
Chao, Grace Yi;
Ng, Wee Teck;
Mitchell, Malcolm I

Publication type:

journal article

Response from Drs. Formica/Zaniboni to Dr. Milano.

Published in:

2016

By:

Formica, V.;
Zaniboni, A.

Publication type:

Letter

Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma.

Published in:

2016

By:

Kahen, Elliot;
Yu, Diana;
Harrison, Douglas;
Clark, Justine;
Hingorani, Pooja;
Cubitt, Christopher;
Reed, Damon;
Harrison, Douglas J;
Cubitt, Christopher L;
Reed, Damon R

Publication type:

journal article

Population pharmacokinetics of bevacizumab in cancer patients with external validation.

Published in:

2016

By:

Han, Kelong;
Peyret, Thomas;
Marchand, Mathilde;
Quartino, Angelica;
Gosselin, Nathalie;
Girish, Sandhya;
Allison, David;
Jin, Jin;
Gosselin, Nathalie H;
Allison, David E

Publication type:

journal article

Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer.

Published in:

2016

By:

Hata, Tsuyoshi;
Kudo, Toshihiro;
Sakai, Daisuke;
Takahashi, Hidekazu;
Haraguchi, Naotsugu;
Nishimura, Junichi;
Hata, Taishi;
Mizushima, Tsunekazu;
Yamamoto, Hirofumi;
Doki, Yuichiro;
Mori, Masaki;
Satoh, Taroh

Publication type:

journal article

Anti-VEGF and anti-EGFR agents open up new horizons changing the landscape for their associations.

Published in:

2016

By:

Milano, Gerard

Publication type:

Letter

Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin lymphoma.

Published in:

2016

By:

Tomono, Ayana;
Ito, Kaori;
Hayashi, Takahiro;
Ando, Maiko;
Ando, Yosuke;
Tsuge, Masahiro;
Okamoto, Akinao;
Inaguma, Yoko;
Okamoto, Masataka;
Emi, Nobuhiko;
Yamada, Shigeki

Publication type:

journal article

Population pharmacokinetics of Reditux™, a biosimilar Rituximab, in diffuse large B-cell lymphoma.

Published in:

2016

By:

Gota, Vikram;
Karanam, Ashwin;
Rath, Sanhita;
Yadav, Akanksha;
Tembhare, Prashant;
Subramanian, P.;
Sengar, Manju;
Nair, Reena;
Menon, Hari

Publication type:

journal article

Cystatin C as a predictor factor in patients with renal cell carcinoma treated by everolimus.

Published in:

2016

By:

Bodnar, Lubomir;
Stec, Rafał;
Dzierżanowska, Małgorzata;
Synowiec, Agnieszka;
Cierniak, Szczepan;
Kade, Grzegorz;
Szczylik, Cezary;
Stec, Rafał;
Dzierżanowska, Małgorzata

Publication type:

journal article

Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer.

Published in:

2016

By:

Fujiwara, Yutaka;
Tamura, Kenji;
Kondo, Shunsuke;
Tanabe, Yuko;
Iwasa, Satoru;
Shimomura, Akihiko;
Kitano, Shigehisa;
Ogasawara, Ken;
Turner, P.;
Mori, Joji;
Asou, Hiroya;
Chan, Edward;
Yamamoto, Noboru;
Turner, P Kellie;
Chan, Edward Michael

Publication type:

journal article

New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanoma.

Published in:

2016

By:

Teuma, Cécile;
Perier-Muzet, Marie;
Pelletier, Solenne;
Nouvier, Mathilde;
Amini-Adl, Mona;
Dijoud, Frédérique;
Duru, Gérard;
Thomas, Luc;
Fouque, Denis;
Laville, Maurice;
Dalle, Stéphane;
Teuma, Cécile;
Dijoud, Frédérique;
Duru, Gérard;
Dalle, Stéphane

Publication type:

journal article

Association of concurrent acid-suppression therapy with survival outcomes and adverse event incidence in oncology patients receiving erlotinib.

Published in:

2016

By:

Lam, Lisa;
Capparelli, Edmund;
Kurzrock, Razelle;
Lam, Lisa H;
Capparelli, Edmund V

Publication type:

journal article

TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer.

Published in:

2016

By:

Ferraro, D.;
Goldstein, D.;
O'Connell, R.;
Zalcberg, J.;
Sjoquist, K.;
Tebbutt, N.;
Grimison, P.;
McLachlan, S.;
Lipton, L.;
Vasey, P.;
Gebski, V.;
Aiken, C.;
Cronk, M.;
Ng, S.;
Karapetis, C.;
Shannon, J.;
O'Connell, R L;
Zalcberg, J R;
Sjoquist, K M;
Tebbutt, N C

Publication type:

journal article

A phase 1, dose-finding and pharmacokinetic study of gemcitabine with nab-paclitaxel in patients with metastatic breast cancer.

Published in:

2016

By:

Yoshitomi, Seiji;
Taira, Naruto;
Doihara, Hiroyoshi;
Mizoo, Taeko;
Nogami, Tomohiro;
Iwamoto, Takayuki;
Motoki, Takayuki;
Shien, Tadahiko;
Ogasawara, Yutaka;
Matsuoka, Junji;
Tsuji, Hisashi;
Mitsuhashi, Toshiharu

Publication type:

journal article

A phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer.

Published in:

2016

By:

Okuma, Yusuke;
Hosomi, Yukio;
Takahashi, Satoshi;
Nakahara, Yoshiro;
Watanabe, Kageaki;
Nagamata, Makoto;
Takagi, Yusuke;
Mikura, Shinichiro

Publication type:

journal article

Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features.

Published in:

2016

By:

Kim, Jwa;
Park, Inkeun;
Lee, Jae;
Kim, Jwa Hoon;
Lee, Jae Lyun

Publication type:

journal article

Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG).

Published in:

2016

By:

Matikas, A.;
Kentepozidis, Ν.;
Ardavanis, A.;
Vaslamatzis, M.;
Polyzos, A.;
Emmanouilides, Ch.;
Katsaounis, P.;
Koinis, F.;
Xynogalos, S.;
Christopoulou, A.;
Ziras, N.;
Tegos, Th.;
Prinarakis, E.;
Hatzidaki, D.;
Georgoulias, V.;
Kotsakis, A.;
Kentepozidis, Ν;
HORG’s Lung Cancer Working Group

Publication type:

journal article

A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors.

Published in:

2016

By:

Mross, Klaus;
Richly, Heike;
Frost, Annette;
Scharr, Dirk;
Nokay, Bahar;
Graeser, Ralph;
Lee, Chooi;
Hilbert, James;
Goeldner, Rainer-George;
Fietz, Oliver;
Scheulen, Max;
Scheulen, Max E

Publication type:

journal article

Panitumumab in combination with irinotecan plus S-1 (IRIS) as second-line therapy for metastatic colorectal cancer.

Published in:

2016

By:

Takaoka, Toshi;
Kimura, Tetsuo;
Shimoyama, Rai;
Kawamoto, Shunji;
Sakamoto, Kazuki;
Goda, Fuminori;
Miyamoto, Hiroshi;
Negoro, Yuji;
Tsuji, Akihito;
Yoshizaki, Koji;
Goji, Takahiro;
Kitamura, Shinji;
Yano, Hiromi;
Okamoto, Koichi;
Kimura, Masako;
Okahisa, Toshiya;
Muguruma, Naoki;
Niitsu, Yoshiro;
Takayama, Tetsuji

Publication type:

journal article

Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations.

Published in:

2016

By:

Mizoguchi, Kosuke;
Nakamura, Yoichi;
Sano, Kazumi;
Sato, Shuntaro;
Ikegami, Yoji;
Motoshima, Kohei;
Takemoto, Shinnosuke;
Ogawara, Daiki;
Senju, Hiroaki;
Sugasaki, Nanae;
Ikeda, Takaya;
Yamaguchi, Hiroyuki;
Nakatomi, Katsumi;
Fukuda, Minoru;
Izumikawa, Koichi;
Mukae, Hiroshi

Publication type:

journal article

Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors.

Published in:

2016

By:

Chow, Laura;
Smith, David;
Tan, Antoinette;
Denlinger, Crystal;
Wang, Ding;
Shepard, Dale;
Chaudhary, Archana;
Lin, Yong;
Gao, Ling;
Chow, Laura Q M;
Smith, David C;
Tan, Antoinette R;
Denlinger, Crystal S;
Shepard, Dale R

Publication type:

journal article

The Best. First. Anti-EGFR before anti-VEGF, in the first-line treatment of RAS wild-type metastatic colorectal cancer: from bench to bedside.

Published in:

2016

By:

Zaniboni, A.;
Formica, V.

Publication type:

journal article